MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0037856
Fabus Pharmaceuticals Private Limited - business services in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.11 Lakh
▼ 30% YoY
Net loss · FY 2025
₹2.82 Lakh
Net margin -34.7%
EBITDA · FY 2025
-₹2.78 Lakh
EBITDA margin -34.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.81 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Fabus Pharmaceuticals Private Limited
Data last updated:
Fabus Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 18 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC340724. Its GSTIN is 10AADCF5377P1ZC (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.81 Lakh. It is led by directors Faiz Iqubal and Farhat Khatoon.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 98 Abul Fazal Enclave, Phase – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.11 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹2.82 Lakh (net margin -34.7%) and EBITDA of -₹2.78 Lakh (EBITDA margin -34.3%).
Fabus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0037856). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fabuspharmaceuticals.com.
Company details
CIN U74999DL2018PTC340724
Registration Number 340724
Incorporation Date 18 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0037856
Key People
Faiz Iqubal Director Farhat Khatoon Director Recognitions & Rankings of Fabus Pharmaceuticals
Contact details
Fabus Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is fabuspharmaceuticals.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressN – 98 Abul Fazal Enclave, Phase – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Fabus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Fabus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Fabus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fabus Pharmaceuticals Private Limited, buy the company report.
Financials of Fabus Pharmaceuticals Private Limited
FY 2025 filings availableFabus Pharmaceuticals Private Limited reported revenue of ₹8.11 Lakh (down 30% YoY) for FY 2025.
Revenue · FY 2025
₹8.11 Lakh ▼ 30%
Net loss · FY 2025
₹2.82 Lakh margin -34.7%
EBITDA · FY 2025
-₹2.78 Lakh margin -34.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▼ 27%
5 years · compounded
▼ 11%
Revenue fell 30% in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.3% | ||||
| Net Profit Margin | -34.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fabus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fabus Pharmaceuticals Private Limited
Fabus Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Faiz Iqubal | Director | 18 Oct 2018 | 8 Years 0 Months | Current |
| Farhat Khatoon | Director | 18 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Fabus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ayutis Pharmaceuticals Private Limited | ₹8.16 Lakh (FY 2024) | Dhanbad, Jharkhand, India | ||||
| Usc Pharmaceuticals Private Limited | ₹8.13 Lakh (FY 2015) | -49.0% | Thane, Maharashtra, India | |||
| Fabus Pharmaceuticals Private Limitedthis company | ₹8.11 Lakh (FY 2025) | -₹2.82 Lakh | -34.7% | -30.0% | New Delhi, Delhi, India | |
| Becure Pharmaceuticals Private Limited | ₹8.09 Lakh (FY 2024) | 58.0% | New Delhi, Delhi, India | |||
| Arisha Pharmaceuticals (OPC) Private Limited | ₹8.07 Lakh (FY 2025) | 26.0% | Raiganj, West Bengal, India | |||
| Ojas Drugs & Pharmaceuticals Private Limited | ₹8.01 Lakh (FY 2024) | -52.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Fabus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fabus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fabus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fabus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCF5377P1ZC | Bihar | Active | 16 Jun 2020 |
To see the full GST registrations and return filing status of Fabus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fabus Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Faiz Iqubal was appointed as Director on 18 Oct 2018.
AGM
Fabus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fabus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Faiz Iqubal was appointed as Director.
Appointed
Farhat Khatoon was appointed as Director.
Incorporation
18 Oct 2018
Fabus Pharmaceuticals Private Limited was registered on 18 Oct 2018 with Roc Delhi I & aged 8 years 11 days as per MCA records.
Frequently asked questions
Fabus Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 18 October 2018 (8+ years old) and is registered under CIN U74999DL2018PTC340724.
Fabus Pharmaceuticals has 2 current directors:
- Faiz Iqubal - Director
- Farhat Khatoon - Director
The latest financial statements of Fabus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Fabus Pharmaceuticals is 10AADCF5377P1ZC, registered in Bihar.
The CIN (Corporate Identification Number) of Fabus Pharmaceuticals is U74999DL2018PTC340724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fabus Pharmaceuticals was incorporated on 18 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Fabus Pharmaceuticals by revenue are Ayutis Pharmaceuticals Private Limited, Usc Pharmaceuticals Private Limited, Becure Pharmaceuticals Private Limited, Arisha Pharmaceuticals (OPC) Private Limited, Ojas Drugs & Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Faiz Iqubal was appointed as Director on 18 Oct 2018. Farhat Khatoon was appointed as Director on 18 Oct 2018.
Yes, Fabus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0037856).
Fabus Pharmaceuticals can be reached through the website fabuspharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Fabus Pharmaceuticals is at N – 98 Abul Fazal Enclave, Phase – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025.